catechin and Colorectal Cancer

catechin has been researched along with Colorectal Cancer in 48 studies

Research

Studies (48)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	10 (20.83)	29.6817
2010's	28 (58.33)	24.3611
2020's	10 (20.83)	2.80

Authors

Authors	Studies
Al-Enazy, A; Al-Ghamdi, MA; Albukhari, A; Harakeh, S; Huwait, EA; Moselhy, SS	1
Chen, S; Kashihara, H; Morine, Y; Nishi, M; Shimada, M; Takasu, C; Tokunaga, T; Wada, Y; Yamada, S	1
Khiewkamrop, P; Parhira, S; Pekthong, D; Richert, L; Somran, J; Srikummool, M; Srisawang, P; Surangkul, D	1
Chhabra, G; Ghosh, A; Guttula, PK; Kiran, S; Patra, A; Purkait, S; Verma, P	1
Bianca Xu, G; Chen, H; Chitrakar, B; Gao, Z; Han, X; Lin, X; Sun, Y; Zhang, Z; Zhao, W; Zhou, K; Zhou, Q	1
Oteiza, PI; Zhu, W	1
Chang, WL; Clapper, ML; Cooper, HS	1
Chen, H; Fang, MZ; Huang, SL; Jin, HY; Kong, DS; Li, M; Sun, Y; Wang, SM; Wang, XF; Wang, Y; Zhang, X	1
Buttar, NS; Della'Zanna, G; Foster, NR; Gostout, CJ; Kalaiger, AM; Kisiel, JB; Kraichely, RE; Larson, MV; Limburg, PJ; Meyers, JP; Patai, ÁV; Schroeder, KW; Sedlack, RE; Sinicrope, FA; Song, LMWK; Sontag, S; Umar, A; Viggiano, TR; Yang, CS	1
Chen, D; Chen, L; Dong, J; Geng, R; Gou, H; Liu, J; Ren, S; Wu, W; Xiang, B; Yang, X; Zhang, Z	1
Ohnishi, M; Sakai, H; Shimizu, M; Shirakami, Y; Tanaka, T	1
Chen, Y; Geng, SS; Han, HY; Li, XT; Li, Y; Wang, XQ; Wu, JS; Xie, CF; Zhang, Q; Zhong, CY; Zhu, JY	1
Dai, J; Hu, Y; Li, X; Wang, Y; Williams, BR; Xu, D; Xu, P; Yan, F; Ying, L; Zhao, Y	1
Cai, YK; Chen, J; Chen, WJ; Hao, Z; Lv, Y; Wang, HP; Wang, X; Ye, T; Zhao, JY	1
Enkhbat, T; Ishikawa, D; Jun, H; Kashihara, H; Nishi, M; Shimada, M; Takasu, C; Tokunaga, T; Tominaga, M; Yoshikawa, K	1
Chen, BC; Ding, YP; Gao, ZL; Rakariyatham, K; Suo, HY; Tong, HR; Xiao, H	1
La, X; Li, H; Li, Z; Yang, Y; Zhang, L	1
Andrade, N; Correia-Branco, A; Ferreira, AC; Martel, F; Silva, C; Soares, ML; Sonveaux, P; Stephenne, J	1
Fukunaga, K; Maruyama, T; Murata, S; Nakayama, K; Nowatari, T; Nozaki, R; Ogawa, K; Ohkohchi, N; Sano, N; Tamura, T	1
Araki, H; Kubota, M; Moriwaki, H; Seishima, M; Shimizu, M; Shirakami, Y; Tanaka, T	1
Bazzoli, F; Belluzzi, A; Bianchi, F; D'Angelo, L; Fazio, C; Fogliano, V; Graziani, G; Montanaro, L; Munarini, A; Pacilli, A; Piazzi, G; Prossomariti, A; Ricciardiello, L	1
Cifuentes-Gomez, T; Escudero-Gilete, ML; Heredia, FJ; Hernanz, D; Jara-Palacios, MJ; Spencer, JP	1
Fang, Y; Hu, F; Wang, Y; Wei, F; Wu, B; Xiong, B	1
Choy, YY; Cremonini, E; Fraga, M; Mackenzie, GG; Oteiza, PI; Waterhouse, AL	1
Goel, A; Okugawa, Y; Toden, S; Tovar-Camargo, OA; Tran, HM	1
Choi, SW; Heo, SC; Kim, Y; Kim, YS; Lee, J; Lee, KL	1
Dudgeon, C; Yu, J	1
Baek, SJ; Eling, TE; Hara, Y; Lee, SH; McEntee, MF; Sukhthankar, M; Yamaguchi, K	1
Baek, SJ; Choi, CK; English, A; Kim, JS; Sukhthankar, M	1
Arts, IC; Goldbohm, RA; Hughes, LA; Simons, CC; van den Brandt, PA; Weijenberg, MP	1
Duthie, GG; Kyle, JA; Little, J; McNeill, G; Sharp, L	1
Adachi, S; Hara, Y; Kubota, M; Moriwaki, H; Sakai, H; Shimizu, M; Shirakami, Y; Tsurumi, H; Yasuda, Y	1
Alberti, S; Baek, SJ; Sukhthankar, M	1
Du, GJ; Rodriguez, M; Wang, CZ; Yuan, CS	1
Araújo, JR; Gonçalves, P; Martel, F	1
Jin, HY; Wang, SM; Zhang, CX	1
Gardner, TR; Grieco, M; Herath, SA; Jang, JH; Kirchoff, D; Naffouje, S; Njoh, L; Shantha Kumara, HM; Whelan, RL; Yan, X	1
Kubota, M; Moriwaki, H; Shimizu, M; Tanaka, T	1
Calway, T; Du, GJ; Du, W; He, TC; Qi, LW; Wang, CZ; Yuan, CS; Zhang, ZY	1
Baek, SJ; Min, KW; Wimalasena, J; Zhang, X	1
Calway, T; Du, GJ; Wang, CZ; Wen, XD; Yu, C; Yuan, CS; Zhang, Z	1
Bird, AR; McInerney, JK; Noakes, M; Record, IR	1
Hamada, H; Iigo, M; Kojima, S; Nomoto, H; Tsuda, H	1
Kawabata, K; Kim, M; Murakami, A; Ohigashi, H	1
Al-Fageeh, M; Carter, O; Dashwood, RH; Dashwood, WM; Li, Q	1
Chuang, JC; Jones, PA; Kwan, JM; Li, TW; Liang, G; Yang, AS; Yoo, CB	1
Kim, M; Murakami, A; Ohigashi, H	1
Edler, L; Groh, B; Hoensch, H; Kirch, W	1

Reviews

5 review(s) available for catechin and Colorectal Cancer

Article	Year
Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention. Cancer prevention research (Philadelphia, Pa.), 2020, Volume: 13, Issue:3 Topics: Aberrant Crypt Foci; Adenoma; Adenomatous Polyposis Coli Protein; Animals; Antineoplastic Agents; Aspirin; Atorvastatin; Carcinogenesis; Catechin; Clinical Trials as Topic; Colon; Colonoscopy; Colorectal Neoplasms; Dietary Supplements; Disease Models, Animal; Humans; Intestinal Mucosa; Lycopene; Mice; Mutation; Treatment Outcome	2020
Prevention of Colorectal Cancer by Targeting Obesity-Related Disorders and Inflammation. International journal of molecular sciences, 2017, Apr-26, Volume: 18, Issue:5 Topics: Animals; Catechin; Colorectal Neoplasms; Humans; Inflammation; Obesity; Phytochemicals; Receptor Protein-Tyrosine Kinases; Tea	2017
Chemoprevention of colorectal cancer by targeting obesity-related metabolic abnormalities. World journal of gastroenterology, 2014, Jul-21, Volume: 20, Issue:27 Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Antihypertensive Agents; Catechin; Cell Transformation, Neoplastic; Colorectal Neoplasms; Diet; Dietary Supplements; Humans; Hypolipidemic Agents; Nutritional Status; Obesity; Risk Factors; Risk Reduction Behavior; Signal Transduction; Treatment Outcome	2014
Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutrition research (New York, N.Y.), 2011, Volume: 31, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Antioxidants; Apoptosis; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Diet; Flavonoids; Fruit; Humans; Phenols; Polyphenols; Propiophenones; Quercetin; Resveratrol; Rutin; Stilbenes; Vegetables	2011
Nutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis. International journal of molecular sciences, 2012, Volume: 13, Issue:1 Topics: Amino Acids, Branched-Chain; Carcinogenesis; Catechin; Colorectal Neoplasms; Cytokines; Dietary Supplements; Humans; Liver Neoplasms; Obesity; Risk Factors	2012

Trials

3 trial(s) available for catechin and Colorectal Cancer

Article	Year
Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia. Cancer prevention research (Philadelphia, Pa.), 2021, Volume: 14, Issue:5 Topics: Aberrant Crypt Foci; Aged; Catechin; Colon; Colonoscopy; Colorectal Neoplasms; Female; Follow-Up Studies; Humans; Intestinal Mucosa; Male; Middle Aged; Neoplasm Recurrence, Local; Placebos; Rectum; Treatment Outcome	2021
Chocolate consumption, fecal water antioxidant activity, and hydroxyl radical production. Nutrition and cancer, 2003, Volume: 47, Issue:2 Topics: Adult; Aged; Analysis of Variance; Antioxidants; Biflavonoids; Body Water; Cacao; Catechin; Colorectal Neoplasms; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Feces; Female; Flavonoids; Humans; Hydroxyl Radical; Iron; Male; Middle Aged; Phenols; Polyphenols; Proanthocyanidins	2003
Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence. World journal of gastroenterology, 2008, Apr-14, Volume: 14, Issue:14 Topics: Aged; Aged, 80 and over; Apigenin; Catechin; Cohort Studies; Colon; Colorectal Neoplasms; Female; Flavonoids; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Surveys and Questionnaires	2008

Other Studies

40 other study(ies) available for catechin and Colorectal Cancer

Article	Year
Enhancement of Annexin V in response to combination of epigallocatechin gallate and quercetin as a potent arrest the cell cycle of colorectal cancer. Brazilian journal of biology = Revista brasleira de biologia, 2021, Volume: 83 Topics: Annexin A5; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Humans; Quercetin	2021
Epigallocatechin‑3‑gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancer‑associated fibroblasts. International journal of oncology, 2022, Volume: 60, Issue:2 Topics: Cancer-Associated Fibroblasts; Catechin; Colorectal Neoplasms; Humans; Neoplasms; Oxidative Coupling; Warburg Effect, Oncologic	2022
Epigallocatechin gallate triggers apoptosis by suppressing de novo lipogenesis in colorectal carcinoma cells. FEBS open bio, 2022, Volume: 12, Issue:5 Topics: Animals; Apoptosis; Catechin; Cell Line, Tumor; Colorectal Neoplasms; Fatty Acids; Humans; Lipogenesis; Mice	2022
Restoration of Altered Oncogenic and Tumor Suppressor microRNA Expression in Breast Cancer and Colorectal Cancer Cell using Epicatechin. Current molecular pharmacology, 2023, Volume: 16, Issue:8 Topics: Breast Neoplasms; Catechin; Cell Line, Tumor; Colorectal Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; RNA, Messenger	2023
Characterization of procyanidin extracts from hawthorn (Crataegus pinnatifida) in human colorectal adenocarcinoma cell line Caco-2, simulated Digestion, and fermentation identified unique and novel prebiotic properties. Food research international (Ottawa, Ont.), 2023, Volume: 165 Topics: Adenocarcinoma; Caco-2 Cells; Catechin; Colorectal Neoplasms; Crataegus; Digestion; Fermentation; Humans; Proanthocyanidins	2023
NADPH oxidase 1: A target in the capacity of dimeric ECG and EGCG procyanidins to inhibit colorectal cancer cell invasion. Redox biology, 2023, Volume: 65 Topics: Caco-2 Cells; Catechin; Cell Line, Tumor; Colorectal Neoplasms; Electrocardiography; Epidermal Growth Factor; ErbB Receptors; Humans; Matrix Metalloproteinase 2; NADPH Oxidase 1; Neoplasm Invasiveness; Proanthocyanidins	2023
Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats. World journal of gastroenterology, 2020, May-07, Volume: 26, Issue:17 Topics: Aberrant Crypt Foci; Animals; Anticarcinogenic Agents; Carcinogenesis; Catechin; Cell Proliferation; Colon; Colorectal Neoplasms; Dimethylhydrazines; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Intestinal Mucosa; Male; Neoplasms, Experimental; Protein Interaction Maps; Rats; Rectum; Signal Transduction	2020
EGCG synergizes the therapeutic effect of irinotecan through enhanced DNA damage in human colorectal cancer cells. Journal of cellular and molecular medicine, 2021, Volume: 25, Issue:16 Topics: Antioxidants; Autophagy; Catechin; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; DNA Damage; Drug Synergism; Drug Therapy, Combination; Humans; Irinotecan; Topoisomerase I Inhibitors	2021
(-)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway. Nutrients, 2017, Jun-03, Volume: 9, Issue:6 Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Humans; Neoplastic Stem Cells; Tea; Wnt Signaling Pathway	2017
(-)-Epigallocatechin-3-gallate and EZH2 inhibitor GSK343 have similar inhibitory effects and mechanisms of action on colorectal cancer cells. Clinical and experimental pharmacology & physiology, 2018, Volume: 45, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Enhancer of Zeste Homolog 2 Protein; Humans; Indazoles; Neoplasm Invasiveness; Pyridones	2018
Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice. World journal of gastroenterology, 2017, Dec-14, Volume: 23, Issue:46 Topics: Aberrant Crypt Foci; Animals; Anticarcinogenic Agents; Azoxymethane; Carcinogenesis; Carcinogens; Catechin; Colon; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Female; Gastrointestinal Microbiome; Humans; Mice; Rectum; RNA, Ribosomal, 16S	2017
Epigallocatechin-3-gallate Enhances Radiation Sensitivity in Colorectal Cancer Cells Through Nrf2 Activation and Autophagy. Anticancer research, 2018, Volume: 38, Issue:11 Topics: Caspase 9; Catechin; Cell Nucleus; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Microtubule-Associated Proteins; NF-E2-Related Factor 2; Protein Transport; Radiation-Sensitizing Agents; Transcriptional Activation	2018
The Effect of Different Treatments of (-)-Epigallocatechin-3-Gallate on Colorectal Carcinoma Cell Lines. Nutrition and cancer, 2018, Volume: 70, Issue:7 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caco-2 Cells; Catechin; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Drug Stability; HCT116 Cells; Humans; Proteins	2018
(-)-Epigallocatechin Gallate (EGCG) Enhances the Sensitivity of Colorectal Cancer Cells to 5-FU by Inhibiting GRP78/NF-κB/miR-155-5p/MDR1 Pathway. Journal of agricultural and food chemistry, 2019, Mar-06, Volume: 67, Issue:9 Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Catechin; Colorectal Neoplasms; DNA Damage; Drug Interactions; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Fluorouracil; Gene Expression; HCT116 Cells; Heat-Shock Proteins; Humans; MicroRNAs; NF-kappa B; Signal Transduction	2019
Selective pro-apoptotic and antimigratory effects of polyphenol complex catechin:lysine 1:2 in breast, pancreatic and colorectal cancer cell lines. European journal of pharmacology, 2019, Sep-15, Volume: 859 Topics: Antineoplastic Agents; Apoptosis; Biological Transport; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Glucose; Humans; Lactic Acid; Lysine; Pancreatic Neoplasms; Polyphenols	2019
(-)-Epigallocatechin-3-gallate suppresses liver metastasis of human colorectal cancer. Oncology reports, 2014, Volume: 31, Issue:2 Topics: Animals; Anticarcinogenic Agents; Antioxidants; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Enzyme Activation; HCT116 Cells; Humans; Liver Neoplasms; Male; Mice; Mice, SCID; Neovascularization, Pathologic; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Vascular Endothelial Growth Factor Receptor-2	2014
A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells. Carcinogenesis, 2014, Volume: 35, Issue:10 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cyclin D1; Eicosapentaenoic Acid; Grape Seed Extract; Humans; Proanthocyanidins; Proto-Oncogene Proteins c-myc; Signal Transduction; TOR Serine-Threonine Kinases	2014
Assessment of white grape pomace from winemaking as source of bioactive compounds, and its antiproliferative activity. Food chemistry, 2015, Sep-15, Volume: 183 Topics: Catechin; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Flavonoids; Flavonols; Humans; Hydroxybenzoates; Mass Spectrometry; Plant Extracts; Quercetin; Vitis	2015
EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells. Journal of pharmacological sciences, 2015, Volume: 128, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Autophagy; Catechin; Cell Transformation, Neoplastic; Cisplatin; Colorectal Neoplasms; Drug Synergism; HT29 Cells; Humans; Microtubule-Associated Proteins; Organoplatinum Compounds; Oxaliplatin; Signal Transduction; Tea; Tumor Cells, Cultured	2015
The PI3K/Akt pathway is involved in procyanidin-mediated suppression of human colorectal cancer cell growth. Molecular carcinogenesis, 2016, Volume: 55, Issue:12 Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Biflavonoids; Caco-2 Cells; Catechin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colon; Colorectal Neoplasms; Humans; Phosphatidylinositol 3-Kinases; Proanthocyanidins; Proto-Oncogene Proteins c-akt; Rectum; Signal Transduction	2016
Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer. Oncotarget, 2016, Mar-29, Volume: 7, Issue:13 Topics: Animals; Antineoplastic Agents; Catechin; Cell Line, Tumor; Colorectal Neoplasms; Drug Resistance, Neoplasm; Fluorouracil; Humans; Mice; Mice, Nude; Neoplastic Stem Cells	2016
Walnut Phenolic Extract and Its Bioactive Compounds Suppress Colon Cancer Cell Growth by Regulating Colon Cancer Stemness. Nutrients, 2016, Jul-21, Volume: 8, Issue:7 Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Catechin; Cell Differentiation; Cell Proliferation; Cell Survival; Chlorogenic Acid; Colorectal Neoplasms; Dietary Supplements; Ellagic Acid; Gallic Acid; HCT116 Cells; Humans; Juglans; Neoplastic Stem Cells; Nuts; Plant Extracts; Republic of Korea; Tumor Cells, Cultured	2016
Green tea and PUMA: a deadly combination? Cancer biology & therapy, 2008, Volume: 7, Issue:6 Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Catechin; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Phenols; Polyphenols; Proto-Oncogene Proteins; Tea	2008
A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer. Gastroenterology, 2008, Volume: 134, Issue:7 Topics: Acetylcysteine; Adenomatous Polyposis Coli; Animals; Antineoplastic Agents, Phytogenic; Camellia sinensis; Catechin; Cell Transformation, Neoplastic; Colorectal Neoplasms; Cycloheximide; Cysteine Proteinase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Fibroblast Growth Factor 2; Genes, APC; HCT116 Cells; HT29 Cells; Humans; Mice; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Processing, Post-Translational; Protein Synthesis Inhibitors; Time Factors; Transfection	2008
A potential proliferative gene, NUDT6, is down-regulated by green tea catechins at the posttranscriptional level. The Journal of nutritional biochemistry, 2010, Volume: 21, Issue:2 Topics: 3' Untranslated Regions; Anticarcinogenic Agents; Catechin; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Half-Life; Humans; Oligonucleotide Array Sequence Analysis; p38 Mitogen-Activated Protein Kinases; Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA Stability; RNA, Messenger; Tea; Time Factors	2010
Dietary flavonol, flavone and catechin intake and risk of colorectal cancer in the Netherlands Cohort Study. International journal of cancer, 2009, Dec-15, Volume: 125, Issue:12 Topics: Aged; Body Mass Index; Catechin; Cohort Studies; Colorectal Neoplasms; Diet; Female; Flavones; Flavonols; Humans; Male; Middle Aged; Netherlands; Risk Factors; Surveys and Questionnaires	2009
Dietary flavonoid intake and colorectal cancer: a case-control study. The British journal of nutrition, 2010, Volume: 103, Issue:3 Topics: Aged; Body Mass Index; Case-Control Studies; Catechin; Colonic Neoplasms; Colorectal Neoplasms; Diet; Feeding Behavior; Female; Flavonoids; Flavonols; Humans; Male; Middle Aged; Polymorphism, Genetic; Rectal Neoplasms; Reference Values; Risk Factors; Scotland; Surveys and Questionnaires; Tea	2010
(-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells. Chemico-biological interactions, 2010, May-14, Volume: 185, Issue:3 Topics: Anticarcinogenic Agents; Caco-2 Cells; Catechin; Cell Line, Tumor; Colorectal Neoplasms; ErbB Receptors; HCT116 Cells; HT29 Cells; Humans; Vascular Endothelial Growth Factor A	2010
(-)-Epigallocatechin-3-gallate (EGCG) post-transcriptionally and post-translationally suppresses the cell proliferative protein TROP2 in human colorectal cancer cells. Anticancer research, 2010, Volume: 30, Issue:7 Topics: Anticarcinogenic Agents; Antigens, Neoplasm; Antioxidants; Catechin; Cell Adhesion Molecules; Colorectal Neoplasms; Dose-Response Relationship, Drug; HCT116 Cells; HT29 Cells; Humans; Protein Biosynthesis; Protein Processing, Post-Translational; RNA, Messenger	2010
Letter to the editor: Panaxadiol's anticancer activity is enhanced by epicatechin. The American journal of Chinese medicine, 2010, Volume: 38, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Camellia sinensis; Catechin; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Synergism; Ginsenosides; Humans; Magnoliopsida; Panax; Phytotherapy; Plant Extracts; Vitis	2010
[Inhibitory effect and mechanism of (-)-epigallocatechin-3-gallate on HT29 and HCT-8 colorectal cancer cell lines and expression of HES1 and JAG1]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2011, Volume: 14, Issue:8 Topics: Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Calcium-Binding Proteins; Catechin; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Flow Cytometry; Homeodomain Proteins; HT29 Cells; Humans; Intercellular Signaling Peptides and Proteins; Jagged-1 Protein; Membrane Proteins; Serrate-Jagged Proteins; Transcription Factor HES-1	2011
Perioperative polyphenon E- and siliphos-inhibited colorectal tumor growth and metastases without impairment of gastric or abdominal wound healing in mouse models. Surgical endoscopy, 2012, Volume: 26, Issue:7 Topics: Abdomen; Analysis of Variance; Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Collagen; Colorectal Neoplasms; Drug Combinations; Female; Laparotomy; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasm Transplantation; Perioperative Period; Pneumoperitoneum, Artificial; Pressure; Random Allocation; Silybin; Silymarin; Stomach; Surgical Wound Dehiscence; Wound Healing	2012
The synergistic apoptotic interaction of panaxadiol and epigallocatechin gallate in human colorectal cancer cells. Phytotherapy research : PTR, 2013, Volume: 27, Issue:2 Topics: Annexin A5; Apoptosis; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Drug Synergism; Ginsenosides; Humans; Molecular Docking Simulation	2013
Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate. Journal of cancer research and clinical oncology, 2012, Volume: 138, Issue:12 Topics: Apoptosis; Caco-2 Cells; Caspase 3; Caspase 7; Catechin; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Down-Regulation; HCT116 Cells; HT29 Cells; Humans; MAP Kinase Signaling System; NF-kappaB-Inducing Kinase; Phosphatidylinositol 3-Kinases; Phosphorylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proteolysis; Signal Transduction; Ubiquitination; Up-Regulation	2012
Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Nutrients, 2012, Nov-08, Volume: 4, Issue:11 Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; HCT116 Cells; Humans; Models, Molecular; Molecular Structure; Polyphenols; Structure-Activity Relationship; Tea	2012
Chemoprevention of colorectal cancer by grape seed proanthocyanidin is accompanied by a decrease in proliferation and increase in apoptosis. Nutrition and cancer, 2004, Volume: 49, Issue:1 Topics: Animals; Antioxidants; Apoptosis; Azoxymethane; Biflavonoids; Carcinogens; Caspase 3; Caspases; Catechin; Cell Division; Colorectal Neoplasms; Immunohistochemistry; Male; Proanthocyanidins; Random Allocation; Rats; Rats, Inbred F344	2004
(-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells. Carcinogenesis, 2005, Volume: 26, Issue:9 Topics: Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Colorectal Neoplasms; Enzyme Activation; Enzyme Precursors; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 7; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; p38 Mitogen-Activated Protein Kinases	2005
Lysosomal trafficking of beta-catenin induced by the tea polyphenol epigallocatechin-3-gallate. Mutation research, 2005, Dec-11, Volume: 591, Issue:1-2 Topics: Anticarcinogenic Agents; beta Catenin; Cadherins; Catechin; Cell Line; Colonic Neoplasms; Colorectal Neoplasms; Genes, Reporter; Humans; Lysosomes; Recombinant Fusion Proteins; Signal Transduction; TCF Transcription Factors; Tea; Transcription Factor 7-Like 2 Protein	2005
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine. Molecular cancer therapeutics, 2005, Volume: 4, Issue:10 Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Transitional Cell; Catechin; Cell Line, Tumor; Colorectal Neoplasms; Cytidine; Decitabine; Deoxycytidine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Female; Gene Silencing; HT29 Cells; Humans; Hydralazine; Male; Procainamide; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction	2005
Modifying effects of dietary factors on (-)-epigallocatechin-3-gallate-induced pro-matrix metalloproteinase-7 production in HT-29 human colorectal cancer cells. Bioscience, biotechnology, and biochemistry, 2007, Volume: 71, Issue:10 Topics: Acetylcysteine; Antioxidants; Catechin; Colorectal Neoplasms; Culture Media; Curcumin; Gallic Acid; Genes, Reporter; HT29 Cells; Humans; Hydrogen Peroxide; Isothiocyanates; Luciferases; Matrix Metalloproteinase 7; RNA, Messenger; Transcription Factor AP-1	2007